Kamada (KMDA) Cash from Operations (2012 - 2026)
Kamada (KMDA) posted quarterly Cash from Operations of 291000.0 for Q1 2026, up 43.27% year-on-year from 203106.12 in Q1 2025, and down 103.85% on a QoQ basis from 7566000.0 in Q4 2025.
Kamada (KMDA) Cash from Operations (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Cash from Operations for 15 consecutive years, with 291000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations rose 43.27% year-over-year to 291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25712000.0 (down 44.18% YoY) and the FY2025 annual result came in at 25490000.0, down 46.44% from the prior year.
- Cash from Operations eased to 291000.0 in Q1 2026 per KMDA's latest filing, from 7566000.0 in the prior quarter.
- Over the last five years, Cash from Operations for KMDA reached as high as 22213000.0 in Q3 2024 and fell as low as 513000.0 in Q1 2025.
- A 5-year average of 5764904.88 and a median of 5465000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 90525.93% — and 2025, when it plunged 150.29%.
- Year by year, Cash from Operations stood at 6742.0 in 2022, then surged by 90525.93% to 6110000.0 in 2023, then soared by 70.18% to 10398000.0 in 2024, then fell by 27.24% to 7566000.0 in 2025, then tumbled by 103.85% to 291000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 291000.0, 7566000.0, and 10416000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -291,000.00 |
| Mar 31, 2026 | -291,000.00 |
| Dec 31, 2025 | 7.57 Mn |
| Dec 31, 2025 | 7.57 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | -513,000.00 |
| Mar 31, 2025 | -513,000.00 |
| Dec 31, 2024 | 10.40 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Dec 31, 2023 | 6.11 Mn |